The Blog

Latest News from the Lab

Megan’s Mission Awards $222,120 in RMS Support

The Children’s Cancer Therapy Development Institute (cc-TDI) has been awarded $222,120 by the Megan’s Mission Foundation to advance three clinical research initiatives focused on Rhabdomyosarcoma

Sharing our Why: Science-Justified Hope

This month, we invite you to join us in supporting pioneering research at cc-TDI, which has served as a beacon of hope for families like ours. Our

Entinostat as a combinatorial therapeutic for RMS

In a groundbreaking study, Entinostat as a combinatorial therapeutic for rhabdomyosarcoma, published earlier this week in Scientific Reports, researchers with the Children’s Cancer Therapy Development

Megan’s Mission Awards $222,120 in RMS Support

The Children’s Cancer Therapy Development Institute (cc-TDI) has been awarded $222,120 by the Megan’s Mission Foundation to advance three clinical research initiatives focused on Rhabdomyosarcoma

Sharing our Why: Science-Justified Hope

This month, we invite you to join us in supporting pioneering research at cc-TDI, which has served as a beacon of hope for families like ours. Our

Entinostat as a combinatorial therapeutic for RMS

In a groundbreaking study, Entinostat as a combinatorial therapeutic for rhabdomyosarcoma, published earlier this week in Scientific Reports, researchers with the Children’s Cancer Therapy Development

Science Nonfiction

Each week we will be featuring the work of a scientist on the cc-TDI team to give you a view into the lab and an update on our progress. While some might argue that the Science Fiction genre is the most imaginative view of the scientific universe, we would argue that some of the actual science happening in our lab might be even more innovative and imaginative….